Literature DB >> 23074812

Antiretroviral therapy (ART) rationing and access mechanisms and their impact on youth ART utilization in Malawi.

Jimmy-Gama Dixon1, Sarah Gibson, Barbara McPake, Ken Maleta.   

Abstract

UNLABELLED: The World Health Organization (WHO) staging is a commonly used rationing mechanism for highly active antiretroviral therapy (HAART) among various HIV infected populations including youths in most developing countries. Rationing is defined as any policy or practice that restricts consumption of or access to certain goods due to its limited supply. However, as HIV prevalence is rapidly increasing among youth, understanding the capacity of the staging approach to achieve HAART uptake in youth is of considerable importance. AIM: This study aimed to explore how HAART rationing and access mechanisms impact on youth's utilization of HAART in Malawi.
METHODS: The study used mixed methods with quantitative analysis of existing Ministry of Health Clinical HIV Unit data used to determine existing levels of youth HAART use. Qualitative methods employed in-depth interviews that interviewed nine ART providers, nine HIV positive youth on HAART and nine HIV positive youth not on HAART; and field observations to nine ART clinics were used to understand HAART rationing and access mechanisms and how such mechanisms impact youth uptake of HAART.
RESULTS: The findings revealed that ART providers use both explicit rationing mechanisms like WHO clinical staging and implicit rationing mechanisms like use of waiting lists, queues and referral in ART provision. However, the WHO staging approach had some challenges in its implementation. It was also observed that factors like non-comprehensive approach to HAART provision, costs incurred to access HAART, negative beliefs and misconceptions about HAART and HIV were among the key factors that limit youth access to HAART.
CONCLUSION: The study recommends that while WHO staging is successful as a rationing mechanism in Malawi, measures should be put in place to improve access to CD4 assessment for clients who may need it. ART providers also need to be made aware of the implicit rationing mechanisms that may affect HAART access. There is also need to improve monitoring of those HIV positive youth not on HAART in order for the system to be able to commence them on treatment on time. Additionally, ART programmes need to address individual, programme and structural/social factors that may affect t youth's access to HAART.

Entities:  

Mesh:

Year:  2011        PMID: 23074812      PMCID: PMC3627693     

Source DB:  PubMed          Journal:  Malawi Med J        ISSN: 1995-7262            Impact factor:   0.875


  12 in total

Review 1.  Rationing of expensive medical care in a transition country--nihil novum?

Authors:  E Krízová; J Simek
Journal:  J Med Ethics       Date:  2002-10       Impact factor: 2.903

2.  Clinical staging of HIV-related illness in Mozambique: performance of nonphysician clinicians based on direct observation of clinical care and implications for health worker training.

Authors:  Paula E Brentlinger; José Vallejo Torres; Pilar Martínez Martínez; Annette Ghee; Johnny Lujan; Rui Bastos; Rolanda Manuel; Florindo M Mudender; Américo Assan
Journal:  J Acquir Immune Defic Syndr       Date:  2010-11       Impact factor: 3.731

Review 3.  Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis.

Authors:  Anthony D Harries; Edwin Libamba; Erik J Schouten; Andrina Mwansambo; Felix M Salaniponi; Rex Mpazanje
Journal:  BMJ       Date:  2004-11-13

4.  Hard choices: rationing antiretroviral therapy for HIV/AIDS in Africa.

Authors:  Sydney Rosen; Ian Sanne; Alizanne Collier; Jonathon L Simon
Journal:  Lancet       Date:  2005 Jan 22-28       Impact factor: 79.321

5.  Interim proposal for a WHO Staging System for HIV infection and Disease.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1990-07-20

6.  Implicit rationing in Britain.

Authors:  H Clarkeburn
Journal:  Fam Pract       Date:  1998-06       Impact factor: 2.267

7.  Malawi's contribution to "3 by 5": achievements and challenges.

Authors:  Edwin Libamba; Simon D Makombe; Anthony D Harries; Erik J Schouten; Joseph Kwong-Leung Yu; Olesi Pasulani; Eustice Mhango; John Aberle-Grasse; Mindy Hochgesang; Eddie Limbambala; Douglas Lungu
Journal:  Bull World Health Organ       Date:  2007-02       Impact factor: 9.408

8.  Who is accessing antiretroviral therapy during national scale-up in Malawi?

Authors:  Simon Makombe; Edwin Libamba; Eustice Mhango; Olga de Ascurra Teck; John Aberle-Grasse; Mindy Hochgesang; Erik J Schouten; Anthony D Harries
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-01-26       Impact factor: 2.184

9.  Identification of beneficiaries of free anti-retroviral drugs in Malawi: a community consensus process.

Authors:  A S Muula; F C Maseko
Journal:  AIDS Care       Date:  2007-05

10.  Disease Progression Among Untreated HIV-Infected Patients in South Ethiopia: Implications for Patient Care.

Authors:  Degu Jerene; Bernt Lindtjørn
Journal:  J Int AIDS Soc       Date:  2005-08-30       Impact factor: 5.396

View more
  3 in total

1.  Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model.

Authors:  Christopher J Hoffmann; James J Lewis; David W Dowdy; Katherine L Fielding; Alison D Grant; Neil A Martinson; Gavin J Churchyard; Richard E Chaisson
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

2.  Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.

Authors:  Andrew Mujugira; Connie Celum; Jordan W Tappero; Allan Ronald; Nelly Mugo; Jared M Baeten
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02       Impact factor: 2.205

Review 3.  Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.

Authors:  Olurotimi A Adejumo; Kathleen M Malee; Patrick Ryscavage; Scott J Hunter; Babafemi O Taiwo
Journal:  J Int AIDS Soc       Date:  2015-09-16       Impact factor: 5.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.